InsiderSignalSign in
← Insider buys

Rabia Gurses Ozden has sold OCUL and made no open-market buys since Feb 2023

Chief Medical Officer at Ocular Therapeutix, Inc.

SEC CIK 0001814883 · Filings on SEC.gov ↗

$0Bought
$96KSold
NoneLast buy

Every filing

3 filings since Feb 2023, newest first

OCULSell

Ocular Therapeutix, Inc

Chief Medical Officer

$31K−4.0%Feb 6
OCULSell

Ocular Therapeutix, Inc

Chief Medical Officer

$38K−8.0%Feb 2
OCULSell

Ocular Therapeutix, Inc

Chief Medical Officer

$27K−6.0%Feb 8

Filings come from SEC EDGAR. Not investment advice.